about
Familial Mediterranean fever: current perspectivesLoss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory diseaseFamilial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for ManagementVasculitis: do we know more to classify better?Reviewing the recommendations for lupus in children.The myths we believed in familial Mediterranean fever: what have we learned in the past years?Three cases of spondyloenchondrodysplasia (SPENCD) with systemic lupus erythematosus: a case series and review of the literature.Tocilizumab treatment in childhood Takayasu arteritis: Case series of four patients and systematic review of the literature.Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants.Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.Familial Mediterranean fever patients homozygous for E148Q variant.Periodic Fever, Aphthosis, Pharyngitis, and Adenitis Syndrome: Analysis of Patients From Two Geographic Areas.Assessment of the HScore for reactive haemophagocytic syndrome in patients with rheumatic diseases.The factors affecting neonatal presentations to the pediatric emergency department.Vertigo in childhood: a retrospective series of 100 children.Comparison of patients with familial Mediterranean fever accompanied with sacroiliitis and patients with juvenile spondyloarthropathy.Coexistence of systemic lupus erythematosus and familial Mediterranean fever.A proposed treatment scheme for chronic recurrent multifocal osteomyelitis (CRMO): a case series of nine patients.A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease.Acceptability and Practicality of the Turkish Translation of Pediatric Gait Arm Legs and Spine in Turkish Children.The performance of different classification criteria in paediatric Behçet's disease.Increased psoriasis frequency in patients with familial Mediterranean fever.Comparing polyarteritis nodosa in children and adults: a single center study.Hypomorphic RAG1 defect in a child presented with pulmonary hemorrhage and digital necrosis.Gastrointestinal system manifestations in juvenile systemic lupus erythematosus.Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis.Performance of the new SLICC classification criteria in childhood systemic lupus erythematosus: a multicentre study.Systems-level analysis of genome wide association study results for a pilot juvenile idiopathic arthritis family study.Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases.In vitro evaluation of effects of sustained anti-TNF release from MPEG-PCL-MPEG and PCL microspheres on human rheumatoid arthritis synoviocytes.A case series of adenosine deaminase 2 deficient patients emphasizing treatment and genotype-phenotype correlations.Anti-interleukin 1 treatment in secondary renal amyloidosis associated with autoinflammatory diseases.Acute phase reactants in the follow-up of patients with FMF.Investigation of the inflammatory cell migration process in familial Mediterranean fever.MEFV gene methylation pattern analysis in familial Mediterranean fever patients with altered expression levels.Comorbidities in patients with Familial Mediterranean Fever.PReS-FINAL-2086: In vitro investigation of the sustained therapeutic effect of etanercept loaded microspheres on human rheumatoid arthritis fibroblast-like synoviocytes.Glucocorticoid treatment in juvenile idiopathic arthritisVasculitis Pathogenesis: Can We Talk About Precision Medicine?Genetic testing for DADA2: How can we avoid missing patients?
P50
Q26751292-E530E602-0145-4E8F-883A-898620EBDC9EQ36649404-D2161F3D-DE3C-47B6-804C-B8DE2C8D97B2Q37716794-7B413743-C907-4031-9DBB-3660F96B94DFQ38284032-B3B76E5C-8C53-4E1F-A6E0-50CAF25A145AQ38374309-78BEA703-A259-44AB-A4E4-145DF7E76F09Q38400573-45C310A3-D9BD-4403-8ECF-DA4E86820094Q38725751-E6617C42-9F0B-4A8A-A189-647D0B012D92Q38925203-26DE94B9-27F9-48D9-8D10-3CF7813D55CEQ40087177-480A42D9-55B6-4012-8045-93F549106A72Q40093291-855529B1-6F37-4082-B4B1-FAF5AE41B627Q40095229-737D46BB-BF6F-492F-A6BD-2A98E0816BB4Q40110559-66129148-772B-4856-B22A-358898472A2FQ40630673-1336E009-2AEC-488F-BF4C-AD7CAB6CB337Q41485321-9B6DA2CD-9D7E-4349-BBE9-EBD02718E0B4Q41640562-E470E02C-3974-496E-8634-8A1BB027505FQ41928011-908D0B32-26CC-42B7-AE29-6ADCAC221A42Q44781467-6E91066D-81DA-4BAB-AB80-BA83A0E62AE5Q46969411-2D0A2C33-42E6-4CD7-8113-1B56E9FEF8EBQ47215980-A05A5BF9-F4F7-4B23-96EB-1EB3125D9CFBQ47266260-97822E14-5A02-4258-9DCE-C36D87EFE0B9Q47395119-2952DB53-8294-4635-AA17-526208E09A7FQ48177856-62B7AC00-4FF4-4E88-BD34-FA2010E2E225Q48260256-80EDA353-0AB3-4502-BD57-6129120FB871Q48522544-F4FBD263-DCE9-4EBB-94A5-03398AFD7219Q48695732-2687C829-C5B9-42FA-A40C-D60895C38DA8Q49719439-1AA779EF-D3AA-44BE-A209-84F7DD8111D9Q50708723-4001043D-8201-4C35-AA78-AA24B30F8D45Q53091981-9619C502-CAB7-4681-86C0-BD33A038C1E6Q53279630-03E645F3-9655-4959-99FB-87B221B930BCQ53543785-5D7314B0-C2B3-4E9E-9465-22F52FEAE442Q53732320-532FCC8D-BE4B-4193-8CCF-72B9663DE3C8Q54066257-63E54914-8651-4ADF-B20F-A6C7D051E157Q54913473-0D14E685-5ECE-4D36-A548-098B484E0B5BQ54917754-8CA4047A-E647-4A74-9B97-0A489E4E8B5EQ55001895-F011EBC8-8A45-4282-8B36-61AB8AC70FF4Q55135743-3B0EB18F-2ABA-49F9-A32C-9DC69BEE0BB3Q55178304-DE2582A5-0435-4793-91F5-4FAE7EF4B478Q57062369-82E90859-5CB5-4B04-9DE4-BDC2D124F1BBQ58781578-8DE6BE4A-1B2E-4AA7-BD53-CAE3BF92BCAEQ64043213-E57D3E97-AD46-409C-B30B-9A45A1289212
P50
description
Turkish researcher
@en
Turks onderzoekster
@nl
հետազոտող
@hy
name
Ezgi D Batu
@nl
Ezgi D Batu
@sl
Ezgi D. Batu
@en
Ezgi D. Batu
@es
Ezgi D. Batu
@pt
Ezgi D. Batu
@tr
type
label
Ezgi D Batu
@nl
Ezgi D Batu
@sl
Ezgi D. Batu
@en
Ezgi D. Batu
@es
Ezgi D. Batu
@pt
Ezgi D. Batu
@tr
prefLabel
Ezgi D Batu
@nl
Ezgi D Batu
@sl
Ezgi D. Batu
@en
Ezgi D. Batu
@es
Ezgi D. Batu
@pt
Ezgi D. Batu
@tr
P106
P1153
36518100100
P1559
Ezgi D. Batu
@tr
P21
P27
P31
P496
0000-0003-1065-2363